Trastuzumab/docetaxel-induced nail dystrophy. [electronic resource]
Producer: 20070123Description: 1334-6 p. digitalISSN:- 0011-9059
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Docetaxel
- Fatal Outcome
- Female
- Humans
- Middle Aged
- Nail Diseases -- chemically induced
- Neoplasm Metastasis
- Receptor, ErbB-2 -- immunology
- Taxoids -- administration & dosage
- Trastuzumab
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.